Caris Life Sciences, Inc. (CAI) has an average rating of overweight and mean price target of $27.08, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $17.20, Change: $+0.21, Percent Change: +1.21%